JP
Jack Prochnau
The University of Texas at San Antonio Health Science Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development, University of Oregon
Research areas: Medicine · Oncology · Cancer Immunotherapy and Biomarkers · Pancreatic and Hepatic Oncology Research · TGF-β signaling in diseases
0000-0003-3243-6346
Employment
Employment history is unavailable.
Education
- 2022 - 2030
- 2019 - 2022
- 2015 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Data from Targeting DDR2 for Treating Pancreatic Cancer Save
- Figure S1 from Targeting DDR2 for Treating Pancreatic Cancer Save
- Figure S2 from Targeting DDR2 for Treating Pancreatic Cancer Save
- Figure S3 from Targeting DDR2 for Treating Pancreatic Cancer Save
- Figure S4 from Targeting DDR2 for Treating Pancreatic Cancer Save
- Supplementary Tables 1-4 from Targeting DDR2 for Treating Pancreatic Cancer Save
- Targeting DDR2 for Treating Pancreatic Cancer Save
- A tRNA gene potential to activate interferon signaling involves selective termination and is suppressible by La protein/SSB Save
- Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory Save
- The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects Save
- The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects Save
- Nucleolar Stress Induction by Oxaliplatin and Derivatives Save